Innate Pharma Prices IPO At $5.24 To $6.06 Per Share

Published: Oct 20, 2006

Innate Pharma SA, a French drug developer, has set the terms of its public offering at EUR4.15 to EUR4.80 ($5.24 to $6.06) per share.

>>> Discuss This Story

Back to news